Agilon Health Inc (NYSE:AGL)’s traded shares stood at 15.27 million during the last session, with the company’s beta value hitting 0.64. At the close of trading, the stock’s price was $3.36, to imply a decrease of -7.44% or -$0.27 in intraday trading. The AGL share’s 52-week high remains $7.73, putting it -130.06% down since that peak but still an impressive 55.36% since price per share fell to its 52-week low of $1.50.
Analysts have given a consensus recommendation of Buy for Agilon Health Inc (AGL), translating to a mean rating of 2.90. Of 10 analyst(s) looking at the stock, 0 analyst(s) give AGL a Sell rating. 0 of those analysts rate the stock as Overweight while 3 advise Hold as 7 recommend it as a Buy.
Agilon Health Inc (NYSE:AGL) trade information
After registering a -7.44% downside in the last session, Agilon Health Inc (AGL) has traded red over the past five days. The 5-day price performance for the stock is -5.88%, and -0.88% over 30 days. With these gigs, the year-to-date price performance is 76.84%.
The extremes give us $2.5 and $3 for target low and target high price respectively. As such, AGL has been trading 10.71% off suggested target high and 25.6% from its likely low.
Agilon Health Inc (AGL) estimates and forecasts
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 3.29% for the past 5-year period. While 2025 is set for a 51.77% return in earnings, projections for the next 5 years are at 45.18% annually.
AGL Dividends
Agilon Health Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Agilon Health Inc (NYSE:AGL)’s Major holders
The next major institution holding the largest number of shares is FMR LLC with 56.93 million shares, or about 13.8418% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $372.3 million.
